Do I Need a Nerve Biopsy or Genetic Test for CIDP?

In most cases, no. Neither a nerve biopsy nor genetic testing is routinely required to diagnose Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) ^[1][2]. Neurologists typically diagnose CIDP using a combination of your clinical symptoms, a neurological exam, and less invasive tests like electromyography (EMG) and nerve conduction studies (NCS) ^[1]. EMG and NCS involve placing small sensors on the skin and using mild electrical impulses to measure how well and how fast your nerves send signals. In some situations, a lumbar puncture (spinal tap) or nerve imaging is used to support the diagnosis, though these tests alone cannot confirm or exclude CIDP ^[3][4].

However, if your symptoms are unusual, your test results are unclear, or you aren’t responding to standard treatments, your doctor might first reassess your diagnosis and then recommend a nerve biopsy or a genetic test to investigate further.

When is a Nerve Biopsy Considered?

A nerve biopsy is an invasive surgical procedure where a small piece of a sensory nerve (usually in the calf) is removed and examined under a microscope. It is generally reserved for cases where noninvasive evaluation has not resolved the diagnosis and the result is likely to change your management ^[5][1].

Your doctor might suggest a biopsy if there is a strong suspicion of a different, treatable condition that mimics CIDP, such as vasculitis (inflammation of the blood vessels) or amyloidosis (a buildup of abnormal proteins) ^[6][5]. If standard CIDP treatments like IVIg (intravenous immunoglobulin) or steroids do not work, it does not automatically mean you need a biopsy; instead, your doctor will likely reassess your diagnosis and treatment plan first ^[5][7].

It is important to know that nerve biopsies have significant limitations and risks:

• Limited specificity: They are not perfectly specific for CIDP. A biopsy can come back normal or show non-specific nerve damage even if you genuinely have the disease ^[8][2].
• Permanent numbness: The procedure involves cutting a sensory nerve, which predictably causes a permanent area of numbness in the skin ^[9].
• Chronic pain: The procedure carries a risk of chronic pain or the formation of a painful nerve scar called a neuroma ^[9][10].

Because of these risks, a biopsy should only be performed when the results could significantly alter your treatment plan ^[5][11].

When is Genetic Testing Reasonable?

Genetic testing involves analyzing your blood or saliva to look for hereditary (inherited) neuropathies, such as Charcot-Marie-Tooth (CMT) disease, which can sometimes look remarkably similar to CIDP ^[12].

Your doctor might recommend genetic testing if you have clues that point toward an inherited condition, including:

• Childhood or early adult onset: Your symptoms began at a very young age ^[13][12].
• Longstanding symptoms: Your weakness or numbness has been present for many years or since childhood ^[14]. While CIDP can also progress slowly, decades-long symptoms raise suspicion for a genetic cause ^[12].
• Physical traits: You have certain skeletal deformities, such as pes cavus (very high arches in the feet), hammertoes, or spinal curvature (scoliosis) ^[12][15].
• Family history: You have blood relatives with similar nerve problems or unexplained walking difficulties ^[12].

Keep in mind that you could still have an inherited neuropathy even if you have no known family history. This can happen if the genetic variant is recessive, if relatives had very mild or unrecognized symptoms, or if the mutation is a new (de novo) change in your DNA ^[15].

Genetic testing is a complex process. A negative test panel does not rule out every inherited neuropathy, and finding a genetic variant (sometimes called a “variant of uncertain significance”) does not automatically explain all your symptoms ^[12]. For this reason, working with a genetic counselor before and after testing is highly recommended.

How These Tests Impact Your Care

If an underlying genetic neuropathy like CMT is found, it changes how your condition is managed. Because inherited neuropathies are not caused by an overactive immune system, immune-suppressing therapies like IVIg or steroids are not expected to improve the inherited neuropathy itself ^[12]. Instead, care often shifts toward physical therapy, supportive devices, and genetic counseling for you and your family.

However, you should never stop or change prescribed treatments without speaking to your neurologist. In rare cases, a person can have both a genetic neuropathy and an acquired condition like CIDP. If symptoms rapidly worsen or change unexpectedly in someone already diagnosed with CMT, doctors may investigate to see if CIDP has developed on top of the existing condition ^[16]. Any new, rapid, or severe symptom changes—like difficulty breathing, swallowing, or sudden, severe weakness—warrant prompt medical attention rather than waiting for elective testing.